Biologics Osiris Appoints Uwe Sommer and Thomas Knapp to its Board of Directors byJosh SandbergFebruary 14, 2017
Biologics Osiris to Present 15 Advanced Clinical and Scientific Abstracts byJosh SandbergApril 13, 2016
Biologics Osiris Provides an Update on a Clinical Review by Blue Cross Blue Shield Association byJosh SandbergMarch 21, 2016
Extremities Grafix Demonstrates Positive Clinical Outcomes in Chronic Complex Wounds with Exposed Tendon and Bone byJosh SandbergMarch 7, 2016
Sports Medicine Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds byJosh SandbergOctober 8, 2015
